These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15010012)

  • 1. Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study.
    Punzi HA; Punzi CF; ;
    Curr Hypertens Rep; 2004 Apr; 6(2):106-10. PubMed ID: 15010012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALLHAT, or the soft science of the secondary end point.
    Messerli FH
    Ann Intern Med; 2003 Nov; 139(9):777-80. PubMed ID: 14597462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for antihypertensive treatment: an update after the ALLHAT study.
    Salvetti A; Ghiadoni L
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S51-4. PubMed ID: 14684673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are thiazide diuretics preferred as first-line therapy for hypertension? An appraisal of The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Scott I; Stowasser M
    Intern Med J; 2003 Jul; 33(7):327-30. PubMed ID: 12823686
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiazide and loop diuretics.
    Sica DA; Carter B; Cushman W; Hamm L
    J Clin Hypertens (Greenwich); 2011 Sep; 13(9):639-43. PubMed ID: 21896142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALLHAT: a critical assessment.
    Sjöholm A
    Blood Press; 2004; 13(2):75-9. PubMed ID: 15182109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
    Xie F; Petitti DB; Chen W
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALLHAT: still providing correct answers after 7 years.
    Einhorn PT; Davis BR; Wright JT; Rahman M; Whelton PK; Pressel SL;
    Curr Opin Cardiol; 2010 Jul; 25(4):355-65. PubMed ID: 20520537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.
    Barzilay JI; Davis BR; Pressel SL; Cutler JA; Einhorn PT; Black HR; Cushman WC; Ford CE; Margolis KL; Moloo J; Oparil S; Piller LB; Simmons DL; Sweeney ME; Whelton PK; Wong ND; Wright JT;
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):153-62. PubMed ID: 22396585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.
    Davis BR; Cutler JA; Gordon DJ; Furberg CD; Wright JT; Cushman WC; Grimm RH; LaRosa J; Whelton PK; Perry HM; Alderman MH; Ford CE; Oparil S; Francis C; Proschan M; Pressel S; Black HR; Hawkins CM
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):342-60. PubMed ID: 8722437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics.
    Weir MR; Flack JM; Applegate WB
    Am J Med; 1996 Sep; 101(3A):83S-92S. PubMed ID: 8876478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
    Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
    Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis.
    Monane M; Gurwitz JH; Bohn RL; Glynn RJ; Levin R; Monette J; Avorn J
    J Am Geriatr Soc; 1997 Jan; 45(1):71-5. PubMed ID: 8994491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What ALLHAT tells us about treating high-risk patients with hypertension and hyperlipidemia.
    Geraci TS; Geraci SA
    J Cardiovasc Nurs; 2003; 18(5):389-95. PubMed ID: 14680343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ALLHAT--the most comprehensive antihypertensive treatment trial in the world. The significance of thiazide diuretics for patients older than 55 years is confirmed].
    Nilsson P
    Lakartidningen; 2003 Feb; 100(6):400-4, 407. PubMed ID: 12607431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.